$830 million deal builds on earlier moves into nutritional ingredients

Good yields and enantioselectivity abide

Venture will combine six active pharmaceutical ingredient production sites in Europe

Facilities are reopening in China but spread of virus outside China is raising concerns

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive, yet fleeting, oxaziridine intermediate

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

The tests can still be used, CDC says, as urgency over possible outbreak grows

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Purchase brings the instrumentation giant into the fight against coronavirus

Results for 2019 show resilience, but coronavirus impact shadows forecasts for this year

Product launches and champagne toasts at instrumentation conference bely worries about infection

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits

Congress opts for open-ended support for federal and local agencies

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Product launches and champagne toasts belied worries about infection

Venture will combine 6 active pharmaceutical ingredient production sites in Europe

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive yet fleeting oxaziridine intermediate

160-million-atom simulation reveals potential drug targets

Shocked to learn how little plastic gets recycled, the duo founded a company so they could make a difference

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

C&EN looks at how scientists are adapting to travel restrictions and working from home

Spring lineup of conferences and events frequented by chemists is slashed

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe

Creating more opportunities for dialogue is just the first step

DRT brings sustainable fragrance ingredients and industrial additives

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel

Complaint alleges trade secret theft, patent infringement on separator films

The technique, called MicroMapping, identifies potential protein interactions on and between cells

Chemical makers brace for a slowdown on the continent

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking

Congress opts for open-ended support for federal and local agencies

C&EN looks at how scientists are working from home and adapting to travel restrictions

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery

Models predict an ‘alloy' of H and O is a metallic fluid in the ice giants' interior

Tobacco-related compounds probably transported on smokers' clothes and bodies

Mechanically chiral rotaxane creates a catalytic pocket a little like an enzyme